Clinical Trial Detail

NCT ID NCT02352025
Title S-equol in Women With Triple Negative Breast Cancer
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements yes
Sponsors The University of Texas Health Science Center at San Antonio
Indications

Her2-receptor negative breast cancer

Therapies

S-equol

Age Groups: adult

Additional content available in CKB BOOST